Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed -737.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating cash flow changed -749.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed -59.4% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes. This reverses 7 consecutive comparable moves in the opposite direction.
Trade receivables changed +79.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed +43.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +9899 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed +78.4% from the comparable as-filed period.
Net income changed +69.1% from the comparable as-filed period.
Gross profit changed +104.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed -402 basis points from the comparable as-filed period.
Revenue changed +117.9% from the comparable as-filed period.
Cash & equivalents changed -43.5% from the comparable as-filed period.
Working capital changed -35.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -54.8% from the comparable as-filed period.
Cost of revenue changed +143.4% from the comparable as-filed period.
Inventory / revenue changed -19168 basis points from the comparable as-filed period.
Receivables / revenue changed -1811 basis points from the comparable as-filed period.
Working capital / assets changed -1145 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -28.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -5250 basis points from the comparable as-filed period.
Operating cash-flow margin changed -5276 basis points from the comparable as-filed period.
Inventory changed -13.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed -646 basis points from the comparable as-filed period.
Current assets changed +2.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capex / revenue changed -26 basis points from the comparable as-filed period.
Total assets changed -1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed -100.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.